Quinazoline derivatives for the treatment of cancer

1 12 4 5 13 21 c2 3 567 The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I wherein Qis CR, Qis N, Qand Qare each CR, Qis CR, Xis N or CRc, Y is CR, Xand Xare each C(R)(R), Ris O. Compounds of Formula I are useful in the treatment of diseases and/or...

Full description

Saved in:
Bibliographic Details
Main Authors Huang, Kenneth He, Veal, James, Barta, Thomas, Smith, Emilie D, Ma, Wei, Ommen, Andy
Format Patent
LanguageEnglish
Published 16.03.2010
Online AccessGet full text

Cover

More Information
Summary:1 12 4 5 13 21 c2 3 567 The current invention is directed toward compounds and pharmaceutically acceptable salts of Formula I wherein Qis CR, Qis N, Qand Qare each CR, Qis CR, Xis N or CRc, Y is CR, Xand Xare each C(R)(R), Ris O. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer The current invention is also directed toward pharmaceutical compositions comprising compounds of the invention.